Long-term Hormone Therapy Best for Prostate Cancer
30th Nov 2005, 01:09 GMT
NEW YORK (Reuters Health) - Men with high-risk prostate cancer fare better when they are treated with at least 12 months of hormone reduction therapy rather than with a shorter duration of treatment, new research suggests.
Long-term Hormone Therapy Best for Prostate Cancer related news:
- Hormone therapy best for prostate cancer — HEALTH
- New Cell Line Helps Prostate Cancer Study — RedOrbit News - Health
- New model of prostate cancer helps identify promising pain treatment — EurekAlert! - Cancer
- Prostate Cancer Breakthrough — RedOrbit News - Health
- Herbs for the prostate? — The Cancer Blog
- A candidate gene approach to searching for low-penetrance breast and prostate cancer genes — Nature Reviews Cancer
- PSA testing: an evolving relationship with prostate cancer screening — Prostate Cancer and Prostatic Diseases
- Stem cell find may lead to prostate cancer cure — Telegraph News | UK News
- UAE orders hormone therapy for ``gay wedding`` men — KeralaNext: International
- UAE: Hormone therapy for gay men — Asian Sex Gazette - Latest News
Latest news from RedOrbit News - Health:
- Pet Shop Boys Fans Know Better _ Why Bother Sharing?
- Corcept Tests Psych. Major Depression Rx
- On Its 30th Anniversary, Smokeout Provides Even More Help Quitting Smoking
- Health Plans and Disease Management Companies Are Seeking To Reduce the Use of the ER for Non-Urgent Care - Urgent Emergency Room Usage October 18, 2006 Audio Conference on CD-ROM
- Invitation Conference Call Analyst Meeting
- As Benefit Costs Rise, Employee Retirement Savings Decline
- Aetna to Help Members Quit Tobacco With New Tobacco Cessation Program
- Lilly: Arxxant Cuts Sight Loss in Diabetes
- SW Doctors PA Launch Affordable Primary Care (APC) Services
- Health Savings Technology Appoints New Management Team to Spearhead Growth in Customer-Directed Healthcare Industry